• Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Ask AI
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)
    • Services
      • Equity Reports (Analyst-Ready)
      • Visibility Upgrades (Quartely + As needed)
      • Investor Mapping
    • Press
    • Ask AI
    • Contact
    • English
      • Deutsch (German)
      • 日本語 (Japanese)
  • info@vasro.de
  • +49 (0)69 90 28 39 81
  • Call us Mon - Fri: 8:30 AM - 6:00 PM
VASRO GmbH
VASRO GmbH
  • Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Ask AI
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)

Press

VASRO GmbH > Press
VASRO GmbH

How to Build Cross-Border Visibility in Investor Relations

  • January 23, 2026
  • Unkategorisiert
Build cross-border visibility in investor relations by combining strategic planning, tailored communication, and digital engagement.
Continue Reading
VASRO GmbH

Investor Targeting in the Asia-Pacific region

  • January 22, 2026
  • Unkategorisiert
Investor targeting in Asia-Pacific requires insight into market trends, investor profiles, and local regulations to maximise opportunities and manage risks.
Continue Reading

Ainos, Inc. (NASDAQ: AIMD) — Initial Equity Report (Non-Rated) | Two Engines: AI Nose Execution + VELDONA® Clinical Gates

  • January 20, 2026
  • Equity Research Coverage
This initiating publication is built to do one job: turn Ainos into a monitorable equity narrative with clear execution gates, instead of a “story stock” people talk about but...
Continue Reading
VASRO GmbH

T+1 Settlement and Liquidity for North American Issuers

  • January 20, 2026
  • Unkategorisiert
T+1 Settlement accelerates trade finality, requiring North American issuers to enhance liquidity management and update operations for faster cash flow.
Continue Reading
VASRO GmbH

United States vs Europe Disclosure Playbooks: A Cross-Border Investor Relations Checklist

  • January 19, 2026
  • Unkategorisiert
United States vs Europe disclosure playbooks: Key compliance steps and differences for cross-border investor relations teams.
Continue Reading
VASRO GmbH

Foreign Private Issuers in the United States: Avoiding Selective Disclosure Pitfalls

  • January 16, 2026
  • Unkategorisiert
Foreign Private Issuers in the U.S. must avoid selective disclosure by ensuring fair, transparent communication to meet SEC standards and investor trust.
Continue Reading
VASRO GmbH

Small- and Mid-Cap Visibility: How to Earn Institutional Attention

  • January 15, 2026
  • Unkategorisiert
Small- and Mid-Cap Visibility improves with strategic outreach, credible research, and consistent communication to attract institutional investors.
Continue Reading
VASRO GmbH

Regulation Fair Disclosure for Investor Relations: What You Can and Cannot Say

  • January 13, 2026
  • Unkategorisiert
Regulation Fair Disclosure requires investor relations to share material info publicly, prohibiting selective updates to analysts or investors.
Continue Reading
VASRO GmbH

EU Market Abuse Regulation for Investor Relations

  • January 12, 2026
  • Unkategorisiert
EU Market Abuse Regulation guides investor relations in managing disclosures, insider lists, and compliance to uphold market integrity.
Continue Reading
VASRO GmbH

EU Capital Markets 2026: Liquidity, Valuations, and What Investor Relations Must Prioritize

  • January 9, 2026
  • Unkategorisiert
EU Capital Markets in 2026 demand investor relations to prioritize transparency, digital engagement, and regulatory compliance for strong liquidity and valuations.
Continue Reading

Posts pagination

Previous 1 … 3 4 5 … 37 Next

Search

Categories

  • Energy
  • Equity Analysis reports
  • Equity Research Coverage
  • Market Intelligence
  • Pharma & Biotech
  • Tech
  • Unkategorisiert

Recent Posts

Sirnaomics Ltd.: The RNAimmune Money Is In, and the FDA Has Answered in Writing on STP705 October 12, 2026
Ainos, Inc.: A Partner Pays for VELDONA, and Ainos Keeps the Platform September 29, 2026
Ainos Inc: A Front-End Customer Starts Ordering, and the Dataset Passes a Billion September 16, 2026
Ainos, Inc.: Three Patents Approved in Japan, and a Dataset Gathering Pace September 11, 2026
Baladna: The Capital Is Raised, Algeria Is Building – VASRO Reiterates BUY at QAR 2.33 September 7, 2026
VASRO GmbH
VASRO GmbH specializes in equity analysis, market intelligence, and investment strategy for the pharmaceutical, biotechnology, and IT sectors. We deliver tailored insights to drive informed investment decisions and achieve exceptional results.

Discover More

Contact Info

  • Am Hauptbahnhof 16, 60329 Frankfurt am Main, Germany
  • +49 (0)69 90 28 39 81
  • info@vasro.de
  • 8:30 AM - 6:00 PM

Navigation

  • Imprint
  • Privacy Policy
  • Change privacy settings
  • Application
  • About
  • FAQ

©copyright 2025 VASRO GmbH.